Ligand id: 7685

Name: mepolizumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: mepolizumab

Compound class Antibody
Approved drug? Yes (EMA & FDA (2015))
International Nonproprietary Names
INN number INN
7876 mepolizumab
Nucala® | SB-240563
The Nucala® brand of mepolizumab is a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in Chinese hamster ovary cells.
Database Links
Specialist databases
IMGT/mAb-DB 87
Other databases
GtoPdb PubChem SID 223366020
Search PubMed clinical trials mepolizumab
Search PubMed titles mepolizumab
Search PubMed titles/abstracts mepolizumab
Wikipedia Mepolizumab